These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Human leukocyte interferon in the treatment of rheumatoid arthritis. Peddinani MV; Savery F; Hang LM Clin Ther; 1986; 9(1):39-43. PubMed ID: 3815460 [TBL] [Abstract][Full Text] [Related]
7. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. van Holten J; Reedquist K; Sattonet-Roche P; Smeets TJ; Plater-Zyberk C; Vervoordeldonk MJ; Tak PP Arthritis Res Ther; 2004; 6(3):R239-49. PubMed ID: 15142270 [TBL] [Abstract][Full Text] [Related]
8. Effects of interferon beta-1B in rheumatoid arthritis: a case report. Jabaily JA; Thompson JS Arthritis Rheum; 1997 Jul; 40(7):1370. PubMed ID: 9214443 [No Abstract] [Full Text] [Related]
9. Lymphoblastoid interferon in chronic hepatitis C patients, 'non-responders' to recombinant interferon-alpha (rIFN-alpha). Cimino L; Citarella C; Nardone G; Budillon G J Hepatol; 1992 Mar; 14(2-3):419-20. PubMed ID: 1500709 [No Abstract] [Full Text] [Related]
10. [alpha-Interferon indices in systemic lupus erythematosus and the effect of interferon therapy]. Barinskiĭ IF; Alekberova ZS; Savinov VA; Pitenov VA; Kuznetsov VP Vopr Virusol; 1983; 28(6):733-6. PubMed ID: 6670258 [TBL] [Abstract][Full Text] [Related]
11. Rheumatoid arthritis subgroup with type I interferon signature: comment on the article by Thurlings et al. Park JK Arthritis Rheum; 2011 Dec; 63(12):4033; author reply 4033-4. PubMed ID: 21882169 [No Abstract] [Full Text] [Related]
17. Recombinant alpha-2a interferon (alpha-IFN) in the treatment of essential thrombocythaemia. Preliminary report. Gugliotta L; Macchi S; Catani L; Chetti L; Mattioli Belmonte M; Guarini A; Criscuolo D; Tura S Haematologica; 1987; 72(3):277-9. PubMed ID: 3114099 [No Abstract] [Full Text] [Related]
18. Therapeutic effect of human recombinant interferon-alpha-2C in essential thrombocythaemia. Velu T; Delwiche F; Gangji D; Monsieur R; Flament J; Stryckmans P; Wybran J; Bellens R Oncology; 1985; 42 Suppl 1():10-4. PubMed ID: 4080296 [TBL] [Abstract][Full Text] [Related]
19. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b. Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic myeloid leukemia by recombinant alpha interferon and hydroxyurea]. Guilhot F; Tanzer J; Brizard A; Dreyfus B; Huret JL; Desmarest MC; Briaut S Presse Med; 1988 Aug 27-Sep 3; 17(29):1494. PubMed ID: 2971200 [No Abstract] [Full Text] [Related] [Next] [New Search]